Evaluation of immunogenicity of Single dose Live Attenuated Varicella Vaccine
Phase 4
- Registration Number
- CTRI/2015/02/005522
- Lead Sponsor
- Wockhardt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
. Healthy children of either sex who received test varicella vaccination (VR 795 varicella Oka strain) as part of the Phase III clinical trial (WOC/VAC/VAR/CT-19-PRT)
. Parent/guardian of subject willing to give written ICF and to comply to all study related procedures
Exclusion Criteria
. Subjects who have not received test varicella vaccine (VR 795 varicella Oka strain) as part of the Phase III clinical trial (WOC/VAC/VAR/CT-19-PRT)
. Any other criteria considered by the Investigator not to be suitable for enrollment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method